We are committed to your health and safety. Check for updates for limited visitor exceptions effective Thursday, March 19, for the novel coronavirus (COVID-19).
Kansas City, Kan. — To continue providing you with efficient, convenient, high-quality care, we are conducting many visits by telehealth. You can connect with a provider from the comfort of your own home. Learn more about telehealth. Call your clini...
Funds will be crucial to the KU Cancer Center’s competitive application for National Cancer Institute (NCI) comprehensive cancer center designation.
Cancer patients are uniquely vulnerable to infectious diseases like COVID-19, which is caused by the coronavirus. For this reason, leaders of The University of Kansas Cancer Center have determined necessary precautions for patients of our cancer cent...
Kansas City, Kan. — The rise of novel coronavirus (COVID-19) is a global, national and local concern. We want to assure our patients and the community that The University of Kansas Health System is working closely with local, state and federal health...
Turning Point is suspending all programs through Friday, April 24.
“This is an example of a group of deeply committed business leaders working in partnership with healthcare leaders to identify and fill a critical need in our ability to fight this terrible virus,” said Bob Page, President and CEO of The University of Kansas Health System.
Social media program 'Bench to Bedside' features cancer research and treatment thought leaders.
The University of Kansas Cancer Center has once again distinguished itself as one of the nation’s best by earning the 2019 Outstanding Achievement Award from the American College of Surgeons’ Commission on Cancer. The cancer center was one of 48 select cancer programs across the country to achieve the distinction.
A historical review authored by members of KU Cancer Center chronicles decades of immune-based research leading to a new frontier in cancer treatment, CAR T-cell therapy.
The goal of the Board is to create back-and-forth communication between community members, organizations and cancer center leaders.
Breast medical oncologist Priyanka Sharma, MD, highlights emerging treatments for metastatic HER2-positive breast cancer in editorial published in The New England Journal of Medicine.
Kansas City, Kan. — Kansas City magazine, formerly 435 Magazine, recently published its annual Top Doctors issue. The magazine partnered with Castle Connolly and asked area physicians to name the most skilled specialists in each field. The Universit...
Today our health system is announcing another major milestone in our efforts to bring proton therapy to academic medicine in Kansas City.
Researchers at The University of Kansas Cancer Center have received a three-year, $900,000 grant from the Ovarian Cancer Research Alliance (OCRA) to better understand why epithelial ovarian cancers take decades to develop as well as identify methods...
Triple-negative breast cancer is unique because it lacks estrogen receptors, progesterone receptors and excess HER2 protein – the drivers of other breast cancer subtypes. It is more aggressive and has a poorer prognosis, primarily because there are f...
